Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,869,606
  • Shares Outstanding, K 35,897
  • Annual Sales, $ 704,590 K
  • Annual Income, $ 73,190 K
  • 60-Month Beta 1.57
  • Price/Sales 4.13
  • Price/Cash Flow 22.72
  • Price/Book 4.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.71
  • Number of Estimates 5
  • High Estimate 0.75
  • Low Estimate 0.64
  • Prior Year 0.67
  • Growth Rate Est. (year over year) +5.97%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.58 +29.81%
on 07/23/19
82.39 -2.97%
on 08/20/19
+17.44 (+27.90%)
since 07/22/19
3-Month
53.10 +50.55%
on 06/04/19
82.39 -2.97%
on 08/20/19
+21.70 (+37.26%)
since 05/22/19
52-Week
45.88 +74.24%
on 10/30/18
82.39 -2.97%
on 08/20/19
+23.58 (+41.84%)
since 08/22/18

Most Recent Stories

More News
Medpace (MEDP) Soars to 52-Week High, Time to Cash Out?

Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

MEDP : 79.94 (-1.47%)
Teladoc Up 33% Year to Date: Will the Momentum Continue?

Teladoc's (TDOC) vast business presence in the growing telehealth industry with many deal wins and international expansion should drive long-term growth.

MEDP : 79.94 (-1.47%)
AMN : 56.27 (-0.11%)
TDOC : 59.78 (-1.37%)
UNH : 232.94 (-3.08%)
Medpace Holdings, Inc. to Present at Baird Global Healthcare Conference

Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will present at the following investor conference in September:

MEDP : 79.94 (-1.47%)
The Zacks Analyst Blog Highlights: Industrial Logistics, Medpace, Unitil, DaVita and Telephone and Data

The Zacks Analyst Blog Highlights: Industrial Logistics, Medpace, Unitil, DaVita and Telephone and Data

MEDP : 79.94 (-1.47%)
TDS : 24.79 (-0.08%)
ILPT : 21.39 (+0.14%)
UTL : 59.52 (-0.58%)
DVA : 55.96 (-1.10%)
5 Stocks to Buy on a Possible Second Rate Cut in September

As signs of deterioration emerge, the central bank may feel compelled to cut rate for the second time in September.

MEDP : 79.94 (-1.47%)
TDS : 24.79 (-0.08%)
ILPT : 21.39 (+0.14%)
UTL : 59.52 (-0.58%)
DVA : 55.96 (-1.10%)
Medpace Holdings, Inc. (MEDP) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Medpace Holdings, Inc. (MEDP).

MEDP : 79.94 (-1.47%)
Medpace (MEDP) Q2 Earnings and Revenues Top Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 28.57% and 6.72%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

MEDP : 79.94 (-1.47%)
Medpace: 2Q Earnings Snapshot

CINCINNATI (AP) _ Medpace Holdings Inc. (MEDP) on Monday reported second-quarter profit of $27.5 million.

MEDP : 79.94 (-1.47%)
Medpace Holdings, Inc. Reports Second Quarter 2019 Results

Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced financial results for the second quarter ended June 30, 2019.

MEDP : 79.94 (-1.47%)
Medpace (MEDP) Earnings Expected to Grow: Should You Buy?

Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MEDP : 79.94 (-1.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade MEDP with:

Business Summary

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

See More

Key Turning Points

2nd Resistance Point 82.87
1st Resistance Point 81.41
Last Price 79.94
1st Support Level 78.94
2nd Support Level 77.93

See More

52-Week High 82.39
Last Price 79.94
Fibonacci 61.8% 68.44
Fibonacci 50% 64.14
Fibonacci 38.2% 59.83
52-Week Low 45.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar